Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Goss SL"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Goss SL; Department of Clinical Pharmacology and Pharmacometrics, AbbVie Inc, North Chicago, Illinois. Electronic address: sandra.goss@abbvie.com., Klein CE; Department of Clinical Pharmacology and Pharmacometrics, AbbVie Inc, North Chicago, Illinois., Jin Z; Department of Data and Statistical Sciences, AbbVie Inc, North Chicago, Illinois., Locke CS; Department of Data and Statistical Sciences, AbbVie Inc, North Chicago, Illinois., Rodila RC; Department of Bioanalysis, AbbVie Inc, North Chicago, Illinois., Kupper H; Department of Immunology Development, AbbVie Deutschland GmbH & Co KG, Ludwigshafen, Germany., Burmester GR; Department of Rheumatology and Clinical Immunology, Charité-University Medicine, Berlin, Germany., Awni WM; Department of Clinical Pharmacology and Pharmacometrics, AbbVie Inc, North Chicago, Illinois.
Publikováno v:
Clinical therapeutics [Clin Ther] 2018 Feb; Vol. 40 (2), pp. 309-319.
Autor:
Burmester GR; Department of Rheumatology and Clinical Immunology, Charité University Hospital, Berlin, Germany., Kaeley GS; Department of Rheumatology, University of Florida College of Medicine, Jacksonville, Florida, USA., Kavanaugh AF; Division of Rheumatology, Allergy and Immunology, University of California San Diego, San Diego, California, USA., Gabay C; Department of Rheumatology, Geneva University Hospitals, University of Geneva, Geneva, Switzerland., MacCarter DK; North Valley Hospital, Whitefish, Montana, USA., Nash P; Department of Medicine, University of Queensland, Brisbane, Queensland, Australia., Takeuchi T; Division of Rheumatology, Department of Internal Medicine, Keio University, Tokyo, Japan., Goss SL; AbbVie, North Chicago, Illinois, USA., Rodila R; AbbVie, North Chicago, Illinois, USA., Chen K; AbbVie, North Chicago, Illinois, USA., Kupper H; AbbVie Deutschland, Ludwigshafen, Germany., Kalabic J; AbbVie Deutschland, Ludwigshafen, Germany.
Publikováno v:
RMD open [RMD Open] 2017 Sep 17; Vol. 3 (2), pp. e000465. Date of Electronic Publication: 2017 Sep 17 (Print Publication: 2017).
Autor:
Kaeley GS; From the University of Florida College of Medicine, Jacksonville, Florida; Arthritis, Rheumatic and Back Disease Associates, Voorhees, New Jersey; Diablo Clinical Research, Walnut Creek, California; AbbVie Inc., North Chicago, Illinois, USA; AbbVie Deutschland GmbH and Co. KG., Ludwigshafen, Germany.G.S. Kaeley, MBBS, MRCP, University of Florida College of Medicine; A.M. Evangelisto, MD, Arthritis, Rheumatic and Back Disease Associates; M.J. Nishio, MD, Diablo Clinical Research; S.L. Goss, PhD, AbbVie Inc.; S. Liu, PhD, AbbVie Inc.; J. Kalabic, MD, AbbVie Inc.; H. Kupper, MD, AbbVie Deutschland GmbH and Co. KG. Gurjit.Kaeley@jax.ufl.edu., Evangelisto AM; From the University of Florida College of Medicine, Jacksonville, Florida; Arthritis, Rheumatic and Back Disease Associates, Voorhees, New Jersey; Diablo Clinical Research, Walnut Creek, California; AbbVie Inc., North Chicago, Illinois, USA; AbbVie Deutschland GmbH and Co. KG., Ludwigshafen, Germany.G.S. Kaeley, MBBS, MRCP, University of Florida College of Medicine; A.M. Evangelisto, MD, Arthritis, Rheumatic and Back Disease Associates; M.J. Nishio, MD, Diablo Clinical Research; S.L. Goss, PhD, AbbVie Inc.; S. Liu, PhD, AbbVie Inc.; J. Kalabic, MD, AbbVie Inc.; H. Kupper, MD, AbbVie Deutschland GmbH and Co. KG., Nishio MJ; From the University of Florida College of Medicine, Jacksonville, Florida; Arthritis, Rheumatic and Back Disease Associates, Voorhees, New Jersey; Diablo Clinical Research, Walnut Creek, California; AbbVie Inc., North Chicago, Illinois, USA; AbbVie Deutschland GmbH and Co. KG., Ludwigshafen, Germany.G.S. Kaeley, MBBS, MRCP, University of Florida College of Medicine; A.M. Evangelisto, MD, Arthritis, Rheumatic and Back Disease Associates; M.J. Nishio, MD, Diablo Clinical Research; S.L. Goss, PhD, AbbVie Inc.; S. Liu, PhD, AbbVie Inc.; J. Kalabic, MD, AbbVie Inc.; H. Kupper, MD, AbbVie Deutschland GmbH and Co. KG., Goss SL; From the University of Florida College of Medicine, Jacksonville, Florida; Arthritis, Rheumatic and Back Disease Associates, Voorhees, New Jersey; Diablo Clinical Research, Walnut Creek, California; AbbVie Inc., North Chicago, Illinois, USA; AbbVie Deutschland GmbH and Co. KG., Ludwigshafen, Germany.G.S. Kaeley, MBBS, MRCP, University of Florida College of Medicine; A.M. Evangelisto, MD, Arthritis, Rheumatic and Back Disease Associates; M.J. Nishio, MD, Diablo Clinical Research; S.L. Goss, PhD, AbbVie Inc.; S. Liu, PhD, AbbVie Inc.; J. Kalabic, MD, AbbVie Inc.; H. Kupper, MD, AbbVie Deutschland GmbH and Co. KG., Liu S; From the University of Florida College of Medicine, Jacksonville, Florida; Arthritis, Rheumatic and Back Disease Associates, Voorhees, New Jersey; Diablo Clinical Research, Walnut Creek, California; AbbVie Inc., North Chicago, Illinois, USA; AbbVie Deutschland GmbH and Co. KG., Ludwigshafen, Germany.G.S. Kaeley, MBBS, MRCP, University of Florida College of Medicine; A.M. Evangelisto, MD, Arthritis, Rheumatic and Back Disease Associates; M.J. Nishio, MD, Diablo Clinical Research; S.L. Goss, PhD, AbbVie Inc.; S. Liu, PhD, AbbVie Inc.; J. Kalabic, MD, AbbVie Inc.; H. Kupper, MD, AbbVie Deutschland GmbH and Co. KG., Kalabic J; From the University of Florida College of Medicine, Jacksonville, Florida; Arthritis, Rheumatic and Back Disease Associates, Voorhees, New Jersey; Diablo Clinical Research, Walnut Creek, California; AbbVie Inc., North Chicago, Illinois, USA; AbbVie Deutschland GmbH and Co. KG., Ludwigshafen, Germany.G.S. Kaeley, MBBS, MRCP, University of Florida College of Medicine; A.M. Evangelisto, MD, Arthritis, Rheumatic and Back Disease Associates; M.J. Nishio, MD, Diablo Clinical Research; S.L. Goss, PhD, AbbVie Inc.; S. Liu, PhD, AbbVie Inc.; J. Kalabic, MD, AbbVie Inc.; H. Kupper, MD, AbbVie Deutschland GmbH and Co. KG., Kupper H; From the University of Florida College of Medicine, Jacksonville, Florida; Arthritis, Rheumatic and Back Disease Associates, Voorhees, New Jersey; Diablo Clinical Research, Walnut Creek, California; AbbVie Inc., North Chicago, Illinois, USA; AbbVie Deutschland GmbH and Co. KG., Ludwigshafen, Germany.G.S. Kaeley, MBBS, MRCP, University of Florida College of Medicine; A.M. Evangelisto, MD, Arthritis, Rheumatic and Back Disease Associates; M.J. Nishio, MD, Diablo Clinical Research; S.L. Goss, PhD, AbbVie Inc.; S. Liu, PhD, AbbVie Inc.; J. Kalabic, MD, AbbVie Inc.; H. Kupper, MD, AbbVie Deutschland GmbH and Co. KG.
Publikováno v:
The Journal of rheumatology [J Rheumatol] 2016 Aug; Vol. 43 (8), pp. 1480-9. Date of Electronic Publication: 2016 Jun 15.
Autor:
Burmester GR; Department of Rheumatology and Clinical Immunology, Charité-University Medicine Berlin, Berlin, Germany., Kivitz AJ; Altoona Center for Clinical Research, Duncansville, Pennsylvania, USA., Kupper H; AbbVie Deutschland GmbH & Co KG, Ludwigshafen, Germany., Arulmani U; AbbVie Inc, North Chicago, Illinois, USA., Florentinus S; AbbVie, Rungis, France., Goss SL; AbbVie Inc, North Chicago, Illinois, USA., Rathmann SS; AbbVie Inc, North Chicago, Illinois, USA., Fleischmann RM; University of Texas Southwestern, Dallas, Texas, USA.
Publikováno v:
Annals of the rheumatic diseases [Ann Rheum Dis] 2015 Jun; Vol. 74 (6), pp. 1037-44. Date of Electronic Publication: 2014 Feb 18.
Autor:
Burmester GR; Charité-University Medicine Berlin, Berlin, Germany., Kivitz A; Altoona Center for Clinical Research, Duncansville, Pennsylvania, USA., Kupper H; AbbVie Deutschland GmbH & Co. KG, Ludwigshafen, Germany., Arulmani U; AbbVie Inc., North Chicago, Illinois, USA., Florentinus S; AbbVie, Rungis, France., Goss SL; AbbVie Inc., North Chicago, Illinois, USA., Rathmann SS; AbbVie Inc., North Chicago, Illinois, USA., Fleischmann RM; University of Texas Southwestern, Dallas, Texas, USA.
Publikováno v:
Annals of the rheumatic diseases [Ann Rheum Dis] 2014 Aug; Vol. 73 (8), pp. e51. Date of Electronic Publication: 2014 Jun 09.
Autor:
Pfeifer ND; University of North Carolina at Chapel Hill, Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, Chapel Hill, North Carolina, USA., Goss SL, Swift B, Ghibellini G, Ivanovic M, Heizer WD, Gangarosa LM, Brouwer KL
Publikováno v:
CPT: pharmacometrics & systems pharmacology [CPT Pharmacometrics Syst Pharmacol] 2013 Jan 02; Vol. 2, pp. e20. Date of Electronic Publication: 2013 Jan 02.
Autor:
Redden L; Abbott, Abbott Park, IL, USA. laura.redden@abbott.com, Rendenbach-Mueller B, Abi-Saab WM, Katz DA, Goenjian A, Robieson WZ, Wang Y, Goss SL, Greco N 4th, Saltarelli MD
Publikováno v:
Journal of clinical psychopharmacology [J Clin Psychopharmacol] 2011 Apr; Vol. 31 (2), pp. 221-5.
Autor:
Goss SL; University of Connecticut, School of Pharmacy, Box 2092, Storrs, CT 0626, USA., Lemons KA, Kerstetter JE, Bogner RH
Publikováno v:
The Journal of pharmacy and pharmacology [J Pharm Pharmacol] 2007 Nov; Vol. 59 (11), pp. 1485-92.